CClinicalTrials.gg
Status unknownNCT03654859SIL-OHCAUpdated May 12, 2022

Silesian Registry of Out-of-Hospital Cardiac Arrests

An observational study in Out-Of-Hospital Cardiac Arrest, sponsored by Silesian Centre for Heart Diseases. Status unknown at 1 site in Poland. Per ClinicalTrials.gov, last updated 2022-05-12.

Sponsored by Silesian Centre for Heart Diseases · Observational

The sponsor has not verified this record recently (last verified Dec 2021), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,560
Sex
All
01

Study summary

Silesian Registry of Out-of-Hospital Cardiac Arrests (SIL-OHCA) which is an initiative of the Voivodeship Rescue Service in Katowice in cooperation with the Silesian Center for Heart Diseases in Zabrze is a prospective, population-based registry of out-of-hospital cardiac arrests (OHCA). The main aim of the SIL-OHCA is to asses the frequency of OHCA in the population of Upper Silesia and analyze prognostic factors for long-term survival in patients with OHCA.

02

Conditions studied

  • Out-Of-Hospital Cardiac Arrest

Keywords

  • OHCA
  • cardiac arrest
  • cardiopulmonary resuscitation
03

In context

Heart Arrest

966 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.

This study's planned enrollment of 1,560 is above the median of 200 across 383 observational studies indexed under Heart Arrest.

Browse Heart Arrest studies →

Lead sponsor

Silesian Centre for Heart Diseases is the lead sponsor of 17 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The area covered by the registry is a part of Silesian Voivodeship, Poland, which is the region of activity of Voivodeship Rescue Service in Katowice. There are 2,700,000 inhabitants in the area covered by the registry. All cases of out-of-hospital cardiac arrest with cardiopulmonary resuscitation started or continued by emergency medical services of Voivodeship Rescue Service in Katowice, as well as cases in which resuscitation is not attempted will be included.

Inclusion criteria

  • Out-of-hospital cardiac arrest treated by emergency medical services of Voivodeship Rescue Service in Katowice.

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,560 participants (estimated)
Patient registry
No

Interventions

  • Othercardiopulmonary resuscitation

    no pre-specified

06

What researchers measure

Primary outcomes

  1. All-cause mortality

    Time frame: 12 months

Secondary outcomes

  1. 30-day survival or survival to discharge

    Time frame: 30 days

  2. Any return of spontaneous circulation

    the occurence of any return of spontaneous circulation after cardiac arrest

    Time frame: from OHCA until transfer to the hospital or decision to withdraw CPR (assessed up to 24 hours after OHCA)

  3. Event survival

    transfer to the hospital with sustained ROSC

    Time frame: within first 24 hours after OHCA

07

Study locations

1 site
  • Voivodeship Rescue Service
    Katowice, Poland
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 12, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03654859
Lead sponsor
Silesian Centre for Heart Diseases
Collaborators
Voivodeship Rescue Service in Katowice
Responsible party
Sponsor
First posted
Aug 31, 2018
Start date
Jan 1, 2018
Primary completion
Dec 31, 2019
Completion
Dec 31, 2023 (estimated)
Last update
May 12, 2022

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion